Overview

A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This prospective, randomized, controlled, multicenter clinical trial will evaluate Opportunity, Validity and Security of Steroids Plus Cyclosporin therapy for patients of Idiopathic Membranous Nephropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Cyclosporine
Cyclosporins
Methylprednisolone